posteditor

posteditor

19.3% Weight Reduction, 16.5 cm Waist Circumference Decrease, SBP/DBP Reductions of 22.9/12.9 mmHg, 70.7 μmol/L Uric Acid Reduction, and 33.6% Triglyceride Reduction: BGM0504 Demonstrates Comprehensive Cardiometabolic Regulation Capabilities

B SUZHOU, China, May 6, 2026 /PRNewswire/ — Recently, BrightGene Bio-Medical Technology Co., Ltd. (hereinafter referred to as “BrightGene Bio-Medical ” or “the Company”) announced… Login to continue reading Login Sign up for complimentary access Sign Up Now Close

Asembia’s AXS26 Summit Showcases the Future of Specialty Pharmacy & Patient Access

B Industry leaders come together to explore new models, emerging trends, and better outcomes for patients with complex conditions FLORHAM PARK, N.J., May 6, 2026 /PRNewswire/ — Asembia’s AXS26 Summit eclipsed another record attendance, further cementing the event as a draw for industry leaders from North America and beyond to discuss the latest and best ways… Login to continue reading Login Sign up for complimentary access Sign Up Now Close